openPR Logo
Press release

Multi Cancer Early Detection Market will Exceed US$ 3,934.79 Million by with a projected CAGR of 16.7% from 2024 to 2032

06-26-2024 01:53 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Multi-cancer Early Detection Market

Multi-cancer Early Detection Market

๐“๐ก๐ž ๐ซ๐ž๐œ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฉ๐ฎ๐›๐ฅ๐ข๐ฌ๐ก๐ž๐ ๐Œ๐ฎ๐ฅ๐ญ๐ข ๐‚๐š๐ง๐œ๐ž๐ซ ๐„๐š๐ซ๐ฅ๐ฒ ๐ƒ๐ž๐ญ๐ž๐œ๐ญ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฏ๐ž๐š๐ฅ๐ฌ ๐ญ๐ก๐š๐ญ ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐”๐’๐ƒ ๐Ÿ—๐Ÿ•๐Ÿ–.๐Ÿ”๐Ÿ‘ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘, ๐ฐ๐ข๐ญ๐ก ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ๐Ÿ”.๐Ÿ•% ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ž๐ ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ. ๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐จ๐Ÿ๐Ÿ๐ž๐ซ ๐š๐ง ๐š๐›๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ž ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐จ๐Ÿ ๐”๐’๐ƒ ๐Ÿ‘,๐Ÿ—๐Ÿ‘๐Ÿ’.๐Ÿ•๐Ÿ— ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.

In the healthcare sector, MCED investigations have become a crucial screening instrument with molecular inspection of tumour connected barometers in bodily fluids with progressive artificial intelligence algorithms. This new approach sanctions the concurrent perception of several cancers while accurately deciding the particular cancer type. Speedily progressing AI technology, the amalgamation of MCED with AI, has surfaced as an eminent trend, inspiring the advancement of the manifold gamut of MCED AI commodities.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/multi-cancer-early-detection-market/request-for-sample

MCED tests are outlined to recognize the premature existence of a broad gamut of cancers. The blood tests intend to discover biomarkers that may indicate the existence of cancer probably prior to current confirmed screening practices detecting it or prior to patients initially available with indications. While MCED examinations are yet in advance, they could, in due course, become exclusive screening and supportive diagnostic instruments. The objectives of MCED tests are factual, discover cancer prematurely which can permit for more efficacious cure enhancing existence rate and finally life cycle.

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ž๐

The market is splintered. The continuing augmentation capability involving alliances, acquisitions, and participation is pushing contention in the marketplace. Some of the companies that are currently dominating the multi cancer early detection market are:
โ€ข Illumina, Inc. (GRAIL, LLC)
โ€ข Exact Sciences Corp.
โ€ข Foundation Medicine, Inc.
โ€ข AnchorDx
โ€ข Guardant Health
โ€ข Burning Rock Biotech Ltd.
โ€ข GENECAST
โ€ข Beijing Lyman Juntai International Medical Technology Development Co.
โ€ข Freenome Holdings, Inc.
โ€ข Elypta AB

๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/buy/3926/2

๐Š๐ž๐ฒ ๐“๐š๐ค๐ž๐š๐ฐ๐š๐ฒ๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ

โ€ข The primary factors propelling the market growth of the multi cancer early detection are the accompanying prevalent customary screening processes and the sustenance of escalated precision levels.
โ€ข The multi cancer early detection market analysis is mainly based on type, end user and region.
โ€ข In 2023, North America dominated the market.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ

๐˜ฝ๐™ฎ ๐™๐™ฎ๐™ฅ๐™š :

โ€ข Liquid Biopsy
โ€ข Gene Panel, LDT
โ€ข Others

๐˜ฝ๐™ฎ ๐™€๐™ฃ๐™™ ๐™๐™จ๐™š๐™ง :

โ€ข Hospitals
โ€ข Diagnostic Laboratories
โ€ข Others

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐€๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ : https://www.polarismarketresearch.com/industry-analysis/multi-cancer-early-detection-market

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

๐™.๐™Ž. ๐™Š๐™ง๐™ฉ๐™๐™ค๐™ฅ๐™š๐™™๐™ž๐™˜ ๐˜ฟ๐™š๐™ซ๐™ž๐™˜๐™š๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/us-orthopedic-devices-market
๐™„๐™ฃ๐™™๐™ช๐™จ๐™ฉ๐™ง๐™ž๐™–๐™ก ๐™ˆ๐™ž๐™˜๐™ง๐™ค๐™—๐™ž๐™ค๐™ก๐™ค๐™œ๐™ฎ ๐™๐™š๐™จ๐™ฉ๐™ž๐™ฃ๐™œ ๐™Ž๐™š๐™ง๐™ซ๐™ž๐™˜๐™š๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/industrial-microbiology-testing-services-market
๐™๐™ก๐™ฉ๐™ง๐™–๐™จ๐™ค๐™ช๐™ฃ๐™™ ๐™‰๐™š๐™š๐™™๐™ก๐™š ๐™‚๐™ช๐™ž๐™™๐™š๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/ultrasound-needle-guides-market
๐™ˆ๐™š๐™ฉ๐™–๐™ซ๐™š๐™ง๐™จ๐™š ๐™ž๐™ฃ ๐™ƒ๐™š๐™–๐™ก๐™ฉ๐™๐™˜๐™–๐™ง๐™š ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/metaverse-in-healthcare-market
๐˜ฝ๐™ค๐™ฃ๐™š ๐™‚๐™ง๐™ค๐™ฌ๐™ฉ๐™ ๐™Ž๐™ฉ๐™ž๐™ข๐™ช๐™ก๐™–๐™ฉ๐™ค๐™ง ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/bone-growth-stimulator-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multi Cancer Early Detection Market will Exceed US$ 3,934.79 Million by with a projected CAGR of 16.7% from 2024 to 2032 here

News-ID: 3554689 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Polyhydroxyalkanoate (PHA) Market Set to Surpass USD 286.23 Million by 2034, Growing at 9.2% CAGR
Polyhydroxyalkanoate (PHA) Market Set to Surpass USD 286.23 Million by 2034, Gro โ€ฆ
Market Size and Share: The global polyhydroxyalkanoate (PHA) market is valued at approximately USD 129.95 million in 2025 and is expected to witness steady growth from 2026 to 2034, registering a projected CAGR of 9.2% over the forecast period. Polaris Market Research has introduced the latest market research report titled Polyhydroxyalkanoate (PHA) Market that highlights the major revenue stream for the forecast period. The report contains clear, reliable, and thorough market dataโ€ฆ
AI-optimization for Quantum Computing Market Projected to Hit USD 611.87 Million by 2034, Rising at 18.8% CAGR | PsiQuantum, QC Ware, Quantagonia
AI-optimization for Quantum Computing Market Projected to Hit USD 611.87 Million โ€ฆ
The quantitative market research report published by Polaris Market Research on AI-optimization for quantum computing market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, AI-optimization for quantum computing market size, financial data, and projected future growth.โ€ฆ
Global Demand Drives Automotive Aramid Fiber Market to USD 1,620.99 Million by 2034 at 6.4% CAGR | Huvis Corporation, Teijin Limited, Kermel S.A.
Global Demand Drives Automotive Aramid Fiber Market to USD 1,620.99 Million by 2 โ€ฆ
The quantitative market research report published by Polaris Market Research on Automotive Aramid Fiber Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Automotive Aramid Fiber Market size, financial data, and projected future growth. All theโ€ฆ
Interventional Oncology Market Projected to Reach USD 5.91 Billion by 2034, Growing at a CAGR of 8.4% from 2026 to 2034
Interventional Oncology Market Projected to Reach USD 5.91 Billion by 2034, Grow โ€ฆ
Market Size and Share: The global interventional oncology market is estimated to be valued at approximately USD 2.87 billion in 2025 and is expected to witness steady growth from 2026 to 2034, registering a CAGR of 8.4% during the forecast period. Polaris Market Research has introduced the latest market research report titled Interventional Oncology Market that highlights the major revenue stream for the forecast period. The report contains clear, reliable, and thoroughโ€ฆ

All 5 Releases


More Releases for MCED

Multi-Cancer Early Detection (MCED) Testing Market to Reach US$ 7.52 Billion by โ€ฆ
The multi-cancer early detection (MCED) testing market reached US$ 1.67 billion in 2023, increased to US$ 1.92 billion in 2024, and is projected to reach US$ 7.52 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033. The market is gaining strong momentum as healthcare systems shift toward preventive oncology and population-level cancer screening. Multi-cancer early detection testing leverages advanced technologies such as liquid biopsy, next-generation sequencing,โ€ฆ
Multi-Cancer Early Detection: Transforming Cancer Screening with Cutting-Edge Bl โ€ฆ
๐Ÿ‘‰ Multi-cancer early detection (MCED) is a breakthrough blood test that screens for many types of cancer at once, unlike traditional methods targeting one cancer type. It detects cancer signals before symptoms appear, enabling earlier treatment and improving survival rates. This approach offers broader, earlier diagnosis to save more lives. โœ… Download Free Sample: https://www.datamintelligence.com/download-sample/multi-cancer-early-detection-testing-market?rk ๐Ÿ’ก How Do Multi-cancer early detection Tests Work? MCED tests analyze biological markers such as circulating tumorโ€ฆ
Multicancer Screening Market Accelerates with Technological Integration Across D โ€ฆ
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Multicancer Screening Market Size, Share & Trends Analysis Report By Test Type (Laboratory Developed Tests (LDTs) and In-Vitro Diagnostics (IVDs)), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Fluorescence In-Situ Hybridization (FISH)), Sample (Tissue, Blood, Saliva, Buccal Swabs), Method (DNA, RNA, and Proteins), Cancer Type (Breast and Gynecologic, Gastrointestinal, Endocrine, Genitourinary, Skin, Brain/Nervousโ€ฆ
Multicancer Screening Market to Reach USD 6.57 Billion by 2031, Fueled by Advanc โ€ฆ
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Multicancer Screening Market Size, Share & Trends Analysis Report By Test Type (Laboratory Developed Tests (LDTs) and In-Vitro Diagnostics (IVDs)), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Fluorescence In-Situ Hybridization (FISH)), Sample (Tissue, Blood, Saliva, Buccal Swabs), Method (DNA, RNA, and Proteins), Cancer Type (Breast and Gynecologic, Gastrointestinal, Endocrine, Genitourinary, Skin, Brain/Nervousโ€ฆ
Multi Cancer Early Detection Market Exclusive Trends Analysis with Forecast to 2 โ€ฆ
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Multi Cancer Early Detection Market by Type (Liquid Biopsy and Gene Panel, LDT And Others.), End-User (Hospitals, Diagnostic Laboratories And Other)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030." The global multi cancer early detection market is estimated to reach over USD 2.63 billion by 2030, exhibiting a CAGR of 14.49% during the forecastโ€ฆ
Multicancer Screening Market Heats Up: Demand for Comprehensive Cancer Detection โ€ฆ
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Multicancer Screening Market Size, Share & Trends Analysis Report By Test Type (Laboratory Developed Tests (LDTs) and In-Vitro Diagnostics (IVDs)), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Fluorescence In-Situ Hybridization (FISH)), Sample (Tissue, Blood, Saliva, Buccal Swabs), Method (DNA, RNA, and Proteins), Cancer Type (Breast and Gynecologic, Gastrointestinal, Endocrine, Genitourinary, Skin, Brain/Nervousโ€ฆ